Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,431
archived clinical trials in
Anemia

42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated:  12/31/1969
849
mi
from 43215
Oklahoma City, OK
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated:  12/31/1969
283
mi
from 43215
Knoxville, TN
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
283
mi
from 43215
Knoxville, TN
Click here to add this to my saved trials
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated:  12/31/1969
1069
mi
from 43215
Austin, TX
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated:  12/31/1969
937
mi
from 43215
Fort Worth, TX
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
937
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated:  12/31/1969
991
mi
from 43215
Houston, TX
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated:  12/31/1969
1144
mi
from 43215
San Antonio, TX
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
Status: Enrolling
Updated:  12/31/1969
328
mi
from 43215
Washington,
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
Status: Enrolling
Updated:  12/31/1969
436
mi
from 43215
Atlanta, GA
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
Status: Enrolling
Updated:  12/31/1969
460
mi
from 43215
Iowa City, IA
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
Status: Enrolling
Updated:  12/31/1969
798
mi
from 43215
New Orleans, LA
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
798
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
Status: Enrolling
Updated:  12/31/1969
4052
mi
from 43215
Brussels,
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)
Status: Enrolling
Updated: 12/31/1969
Investigational Site
4052
mi
from 43215
Brussels,
Click here to add this to my saved trials
Transfusions and Nitric Oxide Level in Preterm Infants
Transfusions and Nitric Oxide Level in Preterm Infants
Status: Enrolling
Updated:  12/31/1969
352
mi
from 43215
Durham, NC
Transfusions and Nitric Oxide Level in Preterm Infants
Transfusions and Nitric Oxide Level in Preterm Infants
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
BEATS 2: Music Therapy in Sickle Cell
BEATS 2: The Effects of Music Therapy on Young Adults With Sickle Cell Disease
Status: Enrolling
Updated:  12/31/1969
129
mi
from 43215
Cleveland, OH
BEATS 2: Music Therapy in Sickle Cell
BEATS 2: The Effects of Music Therapy on Young Adults With Sickle Cell Disease
Status: Enrolling
Updated: 12/31/1969
University Hospitals Seidman Cancer Center
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States
Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States
Status: Enrolling
Updated:  12/31/1969
995
mi
from 43215
Houston, TX
Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States
Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
How Does a Synbiotic Supplement Affect Iron Status During Iron Repletion in Iron Depleted Female Athletes?
How Does a Synbiotic Supplement Affect Iron Status During Iron Repletion in Iron Depleted Female Athletes?
Status: Enrolling
Updated:  12/31/1969
399
mi
from 43215
Scranton, PA
How Does a Synbiotic Supplement Affect Iron Status During Iron Repletion in Iron Depleted Female Athletes?
How Does a Synbiotic Supplement Affect Iron Status During Iron Repletion in Iron Depleted Female Athletes?
Status: Enrolling
Updated: 12/31/1969
Marywood University
399
mi
from 43215
Scranton, PA
Click here to add this to my saved trials
Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
High Dose Cyclophosphamide for the Treatment of Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
Status: Enrolling
Updated:  12/31/1969
345
mi
from 43215
Baltimore, MD
Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
High Dose Cyclophosphamide for the Treatment of Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Oncology Center
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status
Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status
Status: Enrolling
Updated:  12/31/1969
1645
mi
from 43215
Scottsdale, AZ
Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status
Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Arizona
1645
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
Iron Deficiency and FGF23 Regulation in CKD and HF
Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure
Status: Enrolling
Updated:  12/31/1969
274
mi
from 43215
Chicago, IL
Iron Deficiency and FGF23 Regulation in CKD and HF
Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated:  12/31/1969
1974
mi
from 43215
Burbank, CA
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1974
mi
from 43215
Burbank, CA
Click here to add this to my saved trials
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated:  12/31/1969
1958
mi
from 43215
Irvine, CA
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1958
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated:  12/31/1969
1953
mi
from 43215
Lake Forest, CA
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated: 12/31/1969
Research Site
1953
mi
from 43215
Lake Forest, CA
Click here to add this to my saved trials
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated:  12/31/1969
1949
mi
from 43215
National City, CA
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1949
mi
from 43215
National City, CA
Click here to add this to my saved trials
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated:  12/31/1969
1983
mi
from 43215
Torrance, CA
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1983
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated:  12/31/1969
350
mi
from 43215
Charlotte, NC
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Irvine, CA
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
Status: Enrolling
Updated: 12/31/1969
Masimo Clinical Laboratory
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
Status: Enrolling
Updated:  12/31/1969
350
mi
from 43215
Charlotte, NC
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
Status: Enrolling
Updated:  12/31/1969
1982
mi
from 43215
Lomita, CA
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
Status: Enrolling
Updated: 12/31/1969
Torrance Clinical Research
1982
mi
from 43215
Lomita, CA
Click here to add this to my saved trials
Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients
Arginine Therapy for Acute Chest Syndrome in Sickle Cell Disease
Status: Enrolling
Updated:  6/23/2005
2098
mi
from 43215
Oakland, CA
Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients
Arginine Therapy for Acute Chest Syndrome in Sickle Cell Disease
Status: Enrolling
Updated: 6/23/2005
Children's Hospital Oakland
2098
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia
A Multi-Center, Randomized, Blinded, Placebo Controlled, Cross-Over Study to Investigate the Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia
Status: Enrolling
Updated:  8/21/2008
404
mi
from 43215
Norristown, PA
Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia
A Multi-Center, Randomized, Blinded, Placebo Controlled, Cross-Over Study to Investigate the Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia
Status: Enrolling
Updated: 8/21/2008
Luitpold Pharmaceuticals, Inc.
404
mi
from 43215
Norristown, PA
Click here to add this to my saved trials
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia
Status: Enrolling
Updated:  10/6/2008
1982
mi
from 43215
Los Angeles, CA
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia
Status: Enrolling
Updated: 10/6/2008
UCLA Center for Health Sciences
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia
Status: Enrolling
Updated:  10/6/2008
830
mi
from 43215
Tampa, FL
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia
Status: Enrolling
Updated: 10/6/2008
Lee Moffitt Cancer Center
830
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia
Status: Enrolling
Updated:  10/6/2008
138
mi
from 43215
Cleveland, OH
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia
Status: Enrolling
Updated: 10/6/2008
Taussig Cancer Center, Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia
Status: Enrolling
Updated:  10/6/2008
337
mi
from 43215
Hershey, PA
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia
Status: Enrolling
Updated: 10/6/2008
Penn State University Cancer Center
337
mi
from 43215
Hershey, PA
Click here to add this to my saved trials
A Pilot Study of HSCT for Patients With High-Risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen
A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With High Risk Hemoglobinopathy Using a Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism
Status: Enrolling
Updated:  10/16/2008
164
mi
from 43215
Pittsburgh, PA
A Pilot Study of HSCT for Patients With High-Risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen
A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With High Risk Hemoglobinopathy Using a Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism
Status: Enrolling
Updated: 10/16/2008
Children's Hospital of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children
Randomized Field Intervention Trial of H. Pylori Eradication to Reduce Iron Deficiency Among Children in El Paso, Texas
Status: Enrolling
Updated:  6/26/2009
1422
mi
from 43215
El Paso, TX
Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children
Randomized Field Intervention Trial of H. Pylori Eradication to Reduce Iron Deficiency Among Children in El Paso, Texas
Status: Enrolling
Updated: 6/26/2009
Texas Tech University School of Medicine
1422
mi
from 43215
El Paso, TX
Click here to add this to my saved trials
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
Computerized PAINRelieveIt for Adult Sickle Cell Disease
Status: Enrolling
Updated:  7/24/2009
277
mi
from 43215
Chicago, IL
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
Computerized PAINRelieveIt for Adult Sickle Cell Disease
Status: Enrolling
Updated: 7/24/2009
University of Illinois at Chicago Sickle Cell Center and Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease
SALT - Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease
Status: Enrolling
Updated:  8/27/2009
432
mi
from 43215
Atlanta, GA
SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease
SALT - Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease
Status: Enrolling
Updated: 8/27/2009
Children's Healthcare of Altanta
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Status: Enrolling
Updated:  9/21/2009
1973
mi
from 43215
Los Angeles, CA
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Status: Enrolling
Updated: 9/21/2009
Childrens Hospital Los Angeles
1973
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Status: Enrolling
Updated:  9/21/2009
1973
mi
from 43215
Los Angeles, CA
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Status: Enrolling
Updated: 9/21/2009
Childrens Hospital Los Angeles
1973
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Kidney Transplantation in Patients With Sickle Cell Disease
Kidney Transplantation in Patients With Sickle Cell Disease
Status: Enrolling
Updated:  5/25/2010
430
mi
from 43215
Atlanta, GA
Kidney Transplantation in Patients With Sickle Cell Disease
Kidney Transplantation in Patients With Sickle Cell Disease
Status: Enrolling
Updated: 5/25/2010
Mason Outpatient Tranplant Clinic Emory University
430
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD)
Phase II Study of Propranolol as Anti-Adhesive Therapy for Sickle Cell Disease
Status: Enrolling
Updated:  10/7/2010
352
mi
from 43215
Durham, NC
Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD)
Phase II Study of Propranolol as Anti-Adhesive Therapy for Sickle Cell Disease
Status: Enrolling
Updated: 10/7/2010
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
Phase II Randomized Double-Blind Placebo-Controlled Trial of the Omega-3 Fatty Acids Eicosapentaenoic (EPA) and Docosahexaenoic Acid (DHA) in Pediatric Sickle Cell Disease (SCD)
Status: Enrolling
Updated:  10/22/2010
416
mi
from 43215
Philadelphia, PA
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
Phase II Randomized Double-Blind Placebo-Controlled Trial of the Omega-3 Fatty Acids Eicosapentaenoic (EPA) and Docosahexaenoic Acid (DHA) in Pediatric Sickle Cell Disease (SCD)
Status: Enrolling
Updated: 10/22/2010
Thomas Jefferson University Hospital
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
Phase II Randomized Double-Blind Placebo-Controlled Trial of the Omega-3 Fatty Acids Eicosapentaenoic (EPA) and Docosahexaenoic Acid (DHA) in Pediatric Sickle Cell Disease (SCD)
Status: Enrolling
Updated:  10/22/2010
418
mi
from 43215
Philadelphia, PA
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
Phase II Randomized Double-Blind Placebo-Controlled Trial of the Omega-3 Fatty Acids Eicosapentaenoic (EPA) and Docosahexaenoic Acid (DHA) in Pediatric Sickle Cell Disease (SCD)
Status: Enrolling
Updated: 10/22/2010
St. Christopher's Hospital for Children, Drexel University
418
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Status: Enrolling
Updated:  11/17/2010
492
mi
from 43215
White Plains, NY
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Status: Enrolling
Updated: 11/17/2010
New York Presbyterian Hospital
492
mi
from 43215
White Plains, NY
Click here to add this to my saved trials
Steroid Treatment for Sickle Cell Pain Crisis
Randomized Trial of High-dose Intravenous Methylprednisolone and Steroid Taper for Vaso-occlusive Crises in Sickle Cell Disease
Status: Enrolling
Updated:  11/30/2010
995
mi
from 43215
Houston, TX
Steroid Treatment for Sickle Cell Pain Crisis
Randomized Trial of High-dose Intravenous Methylprednisolone and Steroid Taper for Vaso-occlusive Crises in Sickle Cell Disease
Status: Enrolling
Updated: 11/30/2010
Texas Children's Hospital
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Delayed Cord Clamping in Premature Infants
Delayed Cord Clamping: Prevention of Anemia and Hypothermia in Premature Infants
Status: Enrolling
Updated:  3/14/2011
2043
mi
from 43215
Sacramento, CA
Delayed Cord Clamping in Premature Infants
Delayed Cord Clamping: Prevention of Anemia and Hypothermia in Premature Infants
Status: Enrolling
Updated: 3/14/2011
UC Davis Medical Center
2043
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
A Pilot Study of Lenalidomide in Adult Diamond-Blackfan Anemia Patients With Red Blood Cell Transfusion-Dependent Anemia
Status: Enrolling
Updated:  3/21/2011
2100
mi
from 43215
Stanford, CA
Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
A Pilot Study of Lenalidomide in Adult Diamond-Blackfan Anemia Patients With Red Blood Cell Transfusion-Dependent Anemia
Status: Enrolling
Updated: 3/21/2011
Stanford University School of Medicine
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty
Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty
Status: Enrolling
Updated:  6/8/2011
166
mi
from 43215
Detroit, MI
Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty
Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty
Status: Enrolling
Updated: 6/8/2011
Henry Ford Hospital
166
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Ranibizumab for Neovascularization in Sickle Cell Retinopathy
A Phase I Study to Evaluate the Ocular and Non Ocular Safety of Ranibizumab in Treating Neovascularization Secondary to Sickle Cell Retinopathy
Status: Enrolling
Updated:  6/21/2011
164
mi
from 43215
Detroit, MI
Ranibizumab for Neovascularization in Sickle Cell Retinopathy
A Phase I Study to Evaluate the Ocular and Non Ocular Safety of Ranibizumab in Treating Neovascularization Secondary to Sickle Cell Retinopathy
Status: Enrolling
Updated: 6/21/2011
Kresge Eye Institute
164
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
Status: Enrolling
Updated:  7/15/2011
640
mi
from 43215
Boston, MA
Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
Status: Enrolling
Updated: 7/15/2011
Children's Hospital - Boston
640
mi
from 43215
Boston, MA
Click here to add this to my saved trials